BlackRock Inc. Purchases Shares of 1,932,088 Septerna, Inc. $SEPN

BlackRock Inc. bought a new stake in Septerna, Inc. (NASDAQ:SEPN - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,932,088 shares of the company's stock, valued at approximately $64,706,000. BlackRock Inc. owned approximately 4.29% of Septerna at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of SEPN. Goldman Sachs Group Inc. lifted its stake in shares of Septerna by 86.6% in the 4th quarter. Goldman Sachs Group Inc. now owns 2,715,129 shares of the company's stock worth $75,698,000 after acquiring an additional 1,260,409 shares during the period. Vanguard Group Inc. lifted its position in shares of Septerna by 7.4% in the third quarter. Vanguard Group Inc. now owns 1,518,757 shares of the company's stock valued at $28,568,000 after acquiring an additional 104,394 shares in the last quarter. ADAR1 Capital Management LLC raised its holdings in Septerna by 38.9% in the 3rd quarter. ADAR1 Capital Management LLC now owns 1,176,491 shares of the company's stock valued at $22,130,000 after acquiring an additional 329,264 shares during the last quarter. Janus Henderson Group PLC purchased a new stake in Septerna in the first quarter valued at approximately $21,334,000. Finally, First Light Asset Management LLC raised its holdings in shares of Septerna by 18.0% in the 1st quarter. First Light Asset Management LLC now owns 732,860 shares of the company's stock worth $17,611,000 after purchasing an additional 112,049 shares during the period.

Analyst Ratings Changes

Several analysts have recently weighed in on SEPN shares. Wells Fargo & Company raised their target price on Septerna from $48.00 to $50.00 and gave the company an "overweight" rating in a research note on Wednesday, August 12th. Raymond James Financial reissued a "strong-buy" rating and set a $49.00 target price on shares of Septerna in a report on Tuesday, August 11th. Guggenheim upped their price objective on shares of Septerna from $45.00 to $51.00 and gave the company a "buy" rating in a research note on Tuesday, August 11th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Septerna in a report on Friday, July 17th. Finally, JPMorgan Chase & Co. lifted their price objective on Septerna from $38.00 to $48.00 and gave the company an "overweight" rating in a research report on Wednesday, August 19th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Septerna currently has an average rating of "Moderate Buy" and a consensus price target of $52.44.

Insider Buying and Selling at Septerna

In other Septerna news, SVP Daniel D. Long sold 15,000 shares of the firm's stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $35.51, for a total value of $532,650.00. Following the transaction, the senior vice president directly owned 96,412 shares of the company's stock, valued at approximately $3,423,590.12. This trade represents a 13.46% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Elizabeth Bhatt sold 25,000 shares of the stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $44.00, for a total value of $1,100,000.00. Following the completion of the transaction, the chief operating officer directly owned 174,209 shares in the company, valued at $7,665,196. The trade was a 12.55% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 55,095 shares of company stock worth $2,157,967. Company insiders own 5.80% of the company's stock.

Septerna Price Performance

SEPN opened at $38.91 on Monday. Septerna, Inc. has a 12-month low of $11.70 and a 12-month high of $51.10. The stock's 50 day moving average price is $37.29 and its two-hundred day moving average price is $30.84. The firm has a market capitalization of $1.82 billion, a P/E ratio of -72.06 and a beta of 2.29.

Septerna (NASDAQ:SEPN - Get Free Report) last announced its quarterly earnings data on Monday, August 10th. The company reported ($0.29) EPS for the quarter, topping analysts' consensus estimates of ($0.43) by $0.14. Septerna had a negative return on equity of 9.57% and a negative net margin of 24.51%.The company had revenue of $26.75 million during the quarter, compared to the consensus estimate of $19.22 million. As a group, analysts anticipate that Septerna, Inc. will post -1.41 earnings per share for the current year.

Septerna Company Profile

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. GPCRs are the largest and most diverse family of cell membrane receptors and regulate physiological processes in nearly every organ system of the human body.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source